Tabula Rasa HealthCare and Landmark to Improve Patient Outcomes in California and New York  

MOORESTOWN, N.J. and HUNTINGTON BEACH, Calif., May 01, 2017 -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company disrupting the field of medication safety, has licensed the use of its medication risk mitigation platform, MedWise Advisor®, to Landmark, a leading national medical group focused exclusively on the most chronically ill patients.

TRHC Chairman and CEO, Calvin H. Knowlton, PhD, commented, “We look forward to this new partnership with Landmark. This marks the first time Tabula Rasa will license the use of its platform for other clinicians to use in improving therapeutic outcomes. The new application of our solution further proves the flexibility of MedWise Advisor®, and provides a model to address the demand in our pipeline.

This partnership will allow us to expand our services to new and broader markets where we will not only be able to counteract one of the most avoidable causes of death and unintended medical injuries, but also continue to deliver on our goal of improving patient outcomes and lowering costs by reducing the occurrence of adverse drug events.”

Landmark is teaming up with Tabula Rasa to deploy the MedWise Advisor® platform, allowing Landmark clinicians to identify opportunities to improve the safety of their members’ medication profiles. Tabula Rasa’s pharmacist-staffed call centers also will provide “as-needed” clinical support to Landmark’s clinicians. First phase of the program will be launched by Landmark in two of its markets, California and New York.

“Tabula Rasa’s mission clearly aligns with ours,” said Landmark’s Chief Medical Officer, Dr. Michael Le. “Our patients are often on many different medications with the potential for complex interactions and unintended risk. Our Phase One engagement with Tabula Rasa will allow us to proactively identify patients with elevated risk profiles, and more importantly, enable our clinical staff to intervene and improve the patient’s medication regimen before any incident occurs.”

Dr. Le continued, “The ultimate goal of our collaboration is to use Tabula Rasa’s medication decision support tools to help reduce unnecessary hospitalizations and visits to the emergency room within our population, and to keep our patients healthier, with improved quality of life, at home.”

About Landmark
Landmark is helping people age in place, with quality and dignity in their home. Their community-based, physician-led clinical teams are specialized in house calls and deliver medical, behavioral, social and palliative care to individuals with multiple chronic conditions, when and where it’s needed – 24 hours a day, 7 days a week. Their team of mobile clinicians collaborate with patients’ families, caregivers and other medical providers to bring coordinated world-class healthcare to people of any class. Learn more at LandmarkHealth.org.

About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.  Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, please visit: www.trhc.com.

Contact:                                                                                                                              

Media

Dianne Semingson
[email protected] 
T: 215-870-0829

Investors

Bob East or Asher Dewhurst
Westwicke Partners
443-213-0500
[email protected]